Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Calling MDUFMA stakeholders: Reauthorization and potential modification of the Medical Device User Fee and Modernization Act of 2002, which expires after fiscal year 2007, will be the focus of the third annual MDUFMA stakeholder meeting in Gaithersburg, Md. Nov. 17. Agenda items include the user fee structure, premarket review performance goals and the third-party inspection program. Attendees must register online by Oct. 28...
You may also be interested in...
NEJM Study Deems CRP Significant, Compared With Other Cardiac Markers
A recent New England Journal of Medicine study identifying C-reactive protein as a significant marker of coronary heart disease risk may prove to be a boon for CRP diagnostic manufacturers
Validating Reuse: Single-Use Device Oversight Taxes FDA Workload
AdvaMed is pressing FDA to review validation data for all reprocessed single-use devices
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.